Target intelligence / Profile preview

Heavy metal salt

Molecular classification
Inorganic compound, Toxicant, Metal ion
01

Overview

Heavy metal salts represent a diverse group of inorganic or organic compounds containing dense metallic elements such as lead, mercury, arsenic, and cadmium. These substances are primarily recognized as environmental and occupational toxicants rather than therapeutic targets in the conventional sense of drug discovery. Their toxicity is fundamentally driven by their high affinity for sulfhydryl (-SH) groups on essential proteins and enzymes, leading to widespread enzymatic inhibition and structural damage (NIH, 2023). This interference disrupts critical cellular processes, including oxidative stress regulation and DNA repair, which manifests clinically as severe neurotoxicity, nephrotoxicity, and hematologic impairment (StatPearls, 2024). In a pharmacological context, these salts are the pathogens sequestered by chelating agents. Drugs such as dimercaprol, succimer, and penicillamine function as ligands that coordinate with the metal ions to form stable, water-soluble complexes (PubChem, 2024). This process neutralizes the toxicant and promotes its elimination from the body, although the management of such poisoning must account for the potential redistribution of metals during the treatment process.

Other names
Heavy metal ionsToxic metal compoundsMetallic saltsEnvironmental metallic toxicants
02

Mechanism of action

Chelation therapy involves the administration of multi-dentate ligands that form stable, non-toxic, and water-soluble complexes with heavy metal ions, thereby preventing their interaction with cellular macromolecules and facilitating their systemic excretion via renal or biliary routes.

03

Biological functions

Enzyme inhibitionOxidative stress inductionProtein denaturationDisruption of metal homeostasisDNA damage induction
04

Disease associations

Heavy metal poisoningNeurotoxicityNephrotoxicityLead poisoning (Plumbism)Mercury poisoning (Hydrargyria)ArsenicosisCadmium toxicity
05

Safety considerations

Redistribution of metals to the central nervous system during chelationIatrogenic depletion of essential endogenous minerals (e.g., zinc, calcium)Potential for nephrotoxicity from the excreted metal-chelator complexHypocalcemia risk with EDTA variantsHypersensitivity reactions to sulfonated chelating agents
06

Interacting drugs

Dimercaprol

5 more in the full profile.

07

Biomarkers

Blood lead level (BLL)Urinary mercury concentrationSerum arsenic levelWhole blood cadmiumZinc protoporphyrinDelta-aminolevulinic acid dehydratase (ALAD) activity

Beyond the preview

Go deeper on Heavy metal salt.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heavy metal salt.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call